{"certainAgreement":{"otherDetails":"PI's are required to abide by the sponsor's publication guidelines which require review by coauthors and subsequent review and approval by the sponsor.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"This study stopped accrual early due to unmet targeted accrual goals with 16 subjects registered out of 140 planned (11 randomized out of 132 planned). Patients that were not randomized in Step 2 were not followed further. All data is reported as intent-to-treat except for the adverse event outcome measure, which is reported as as-treated."},"pointOfContact":{"email":"seiferheldw@nrgoncology.org","organization":"NRG Oncology","phone":"215-574-3208","title":"Wendy Seiferheld"}}